Home
Drugs
Pomalidomide
Clinical Trials

Clinical Trials Related to Pomalidomide

Related studies linked through entity extraction aliases.

A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide Refractory

Status: NOT_YET_RECRUITING
Phase: PHASE1/PHASE2

A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

A Study of Belantamab Mafodotin in Combination With Nirogacestat and Pomalidomide in People With Multiple Myeloma That Has Not Responded to Treatment or Has Come Back After Treatment

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma

Status: TERMINATED
Phase: PHASE1

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

Status: RECRUITING
Phase: PHASE3

Phase II Study of Carfilzomib, Pomalidomide, and Dexamethasone for Myeloma Patients Who Had Relapsed or Progressed After Carfilzomib, Lenalidomide, and Dexamethasone

Status: UNKNOWN
Phase: PHASE2

A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis

Status: RECRUITING
Phase: PHASE1/PHASE2

A Study of Daratumumab

Status: RECRUITING
Phase: PHASE3

PVd Versus Vd in NDMM Patients With RI

Status: UNKNOWN
Phase: PHASE2

Study of Combination POM, BTZ, Low-Dose DEX, and DARA (PVD-DARA) in Patients With RRMM

Status: WITHDRAWN
Phase: PHASE1/PHASE2

SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Sequential Treatment With RO-MTX After Pomalidomide, Orelabrutinib, Rituximab (POR) in Newly-diagnosed PCNSL

Status: RECRUITING
Phase: PHASE2

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

Status: RECRUITING
Phase: PHASE1

Clinical Research of Pomalidomide Maintenance Therapy for Primary Multiple Myeloma

Status: RECRUITING
Phase: NA

A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor

Status: NOT_YET_RECRUITING
Phase: PHASE2

Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma

Status: TERMINATED
Phase: PHASE2

A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple Myeloma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

A Study of the Efficacy and Safety of Pomalidomide Capsules Combined With Low-Dose Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma

Status: UNKNOWN
Phase: PHASE3

Belantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma

Status: RECRUITING
Phase: PHASE2